Posts Tagged ‘American Diabetes Association’

Systematically Preventing Obesity and Diabetes Care

June 6, 2022 — Two ideas are hard to miss at the annual Scientific Sessions of the American Diabetes Association. One is that it’s getting harder to treat and prevent diabetes adequately without treating obesity. Second is that health systems can’t handle this reality. They are systematically preventing adequate obesity and diabetes care. Distinct but Overlapping Diseases Let’s get […]

Tirzepatide Data Signal a New Era in Obesity Treatment

June 5, 2022 — This is what you might call a clean sweep. At the Scientific Sessions of the ADA and in NEJM yesterday, researchers unveiled detailed data on tirzepatide for obesity. When Lilly gave us a peek at these data a month ago, “Wow!” was our response. With the full details in view and peer reviewed, we tend […]

Lilly Decides to Advance Tirzepatide for Obesity

June 14, 2019 — It was odd. Lilly had a promising new drug for diabetes that delivered unusually good weight outcomes. But they weren’t sure about developing it for obesity. That was last October. Now, though, they seem to have decided to move ahead with their dual GIP/GLP-1 agonist, tirzepatide, for obesity. Pivotal phase 3 trials will begin this […]

PIONEER Studies Converge at the ADA Meeting

June 9, 2019 — Some of the most discussed news coming from the American Diabetes Association Scientific Sessions in San Francisco is all about the PIONEER studies of oral semaglutide. This drug is presently under review at FDA for type 2 diabetes. Interest is keen because it will be the first of its class that doesn’t require an injection. […]

Myth-Busting, Confusion, and Deception

June 18, 2018 — Myth-busting is a popular approach for tackling controversial or misunderstood subjects. Certainly you’ll find a bit of that here at ConscienHealth. We’re not shy about dispelling myths. But Derek Powell and colleagues conclude that myth-busting can become deceptive. If the question at hand is subtle – not starkly true or false – then myth-busting can leave readers […]

Relentless Change Ahead for Type 2 Diabetes Care

March 8, 2018 — Recent news makes it clear. You can be sure that relentless change lies ahead for type 2 diabetes care. The American College of Physicians (ACP, representing 152,000 internists) is fighting with the American Diabetes Association and other experts over the standard of care. And Scandinavian researchers have found that we might do well to split […]

Evidence-Based Weight Control in the VA Health System

June 25, 2013 — One of the greatest challenges for addressing obesity is delivering evidence-based weight control at a scale that will have meaningful impact. Oh, and we’d like it to be affordable. At the 2013 Scientific Sessions of the American Diabetes Association in Chicago yesterday, a team of researchers presented data suggesting they can do just that in […]

New Diabetes Treatment Standards Put Obesity Up Front

May 16, 2013 — New diabetes treatment guidelines published by the American Association of Clinical Endocrinologists (AACE) provide a central role for obesity treatment. These guidelines are the result of a trend that has taken shape over the last five years as the role of obesity in the growing prevalence of diabetes has become impossible to ignore. Five years […]